Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Crystallization and preliminary X-ray diffraction analysis of the protease from Southampton norovirus complexed with a Michael acceptor inhibitor.

Hussey RJ, Coates L, Gill RS, Wright JN, Sarwar M, Coker S, Erskine PT, Cooper JB, Wood S, Clarke IN, Lambden PR, Broadbridge R, Shoolingin-Jordan PM.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Nov 1;66(Pt 11):1544-8. doi: 10.1107/S1744309110039059. Epub 2010 Oct 29.

2.

A structural study of norovirus 3C protease specificity: binding of a designed active site-directed peptide inhibitor.

Hussey RJ, Coates L, Gill RS, Erskine PT, Coker SF, Mitchell E, Cooper JB, Wood S, Broadbridge R, Clarke IN, Lambden PR, Shoolingin-Jordan PM.

Biochemistry. 2011 Jan 18;50(2):240-9. Epub 2010 Dec 15.

3.

Structural and inhibitor studies of norovirus 3C-like proteases.

Takahashi D, Kim Y, Lovell S, Prakash O, Groutas WC, Chang KO.

Virus Res. 2013 Dec 26;178(2):437-44. doi: 10.1016/j.virusres.2013.09.008. Epub 2013 Sep 17.

4.

Crystallization and preliminary crystallographic study of Porcine epidemic diarrhea virus main protease in complex with an inhibitor.

Tan Y, Wang F, Chen X, Wang J, Zhao Q, Li S, Wang Z, Fu S, Chen C, Yang H.

Acta Crystallogr F Struct Biol Commun. 2014 Dec 1;70(Pt 12):1608-11. doi: 10.1107/S2053230X14021876. Epub 2014 Nov 14.

5.

Structure-guided design and optimization of dipeptidyl inhibitors of norovirus 3CL protease. Structure-activity relationships and biochemical, X-ray crystallographic, cell-based, and in vivo studies.

Galasiti Kankanamalage AC, Kim Y, Weerawarna PM, Uy RA, Damalanka VC, Mandadapu SR, Alliston KR, Mehzabeen N, Battaile KP, Lovell S, Chang KO, Groutas WC.

J Med Chem. 2015 Apr 9;58(7):3144-55. doi: 10.1021/jm5019934. Epub 2015 Mar 19.

6.

Structure-based design and functional studies of novel noroviral 3C protease chimaeras offer insights into substrate specificity.

Herod MR, Prince CA, Skilton RJ, Ward VK, Cooper JB, Clarke IN.

Biochem J. 2014 Dec 15;464(3):461-72. doi: 10.1042/BJ20140959.

7.

Crystallization and preliminary X-ray crystallographic studies of recombinant human leukotriene A4 hydrolase complexed with bestatin.

Tsuge H, Ago H, Aoki M, Furuno M, Noma M, Miyano M, Minami M, Izumi T, Shimizu T.

J Mol Biol. 1994 May 20;238(5):854-6.

PMID:
8182755
8.

Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease.

Damalanka VC, Kim Y, Alliston KR, Weerawarna PM, Galasiti Kankanamalage AC, Lushington GH, Mehzabeen N, Battaile KP, Lovell S, Chang KO, Groutas WC.

J Med Chem. 2016 Mar 10;59(5):1899-913. doi: 10.1021/acs.jmedchem.5b01464. Epub 2016 Feb 8.

9.

Structure-based exploration and exploitation of the S4 subsite of norovirus 3CL protease in the design of potent and permeable inhibitors.

Galasiti Kankanamalage AC, Kim Y, Rathnayake AD, Damalanka VC, Weerawarna PM, Doyle ST, Alsoudi AF, Dissanayake DM, Lushington GH, Mehzabeen N, Battaile KP, Lovell S, Chang KO, Groutas WC.

Eur J Med Chem. 2017 Jan 27;126:502-516. doi: 10.1016/j.ejmech.2016.11.027. Epub 2016 Nov 14.

PMID:
27914364
10.

Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors.

Mandadapu SR, Gunnam MR, Tiew KC, Uy RA, Prior AM, Alliston KR, Hua DH, Kim Y, Chang KO, Groutas WC.

Bioorg Med Chem Lett. 2013 Jan 1;23(1):62-5. doi: 10.1016/j.bmcl.2012.11.026. Epub 2012 Nov 21.

11.

Crystallization and preliminary crystallographic study of Feline infectious peritonitis virus main protease in complex with an inhibitor.

Wang J, Wang F, Tan Y, Chen X, Zhao Q, Fu S, Li S, Chen C, Yang H.

Acta Crystallogr F Struct Biol Commun. 2014 Dec 1;70(Pt 12):1612-5. doi: 10.1107/S2053230X14022390. Epub 2014 Nov 14.

12.

Crystallization of an enzyme-inhibitor complex: proteinase K with its protein inhibitor, PK13.

Pal GP, Jany KD, Tsernoglou D.

Proteins. 1994 Jun;19(2):161-2.

PMID:
8090711
13.

Characterization and inhibition of norovirus proteases of genogroups I and II using a fluorescence resonance energy transfer assay.

Chang KO, Takahashi D, Prakash O, Kim Y.

Virology. 2012 Feb 20;423(2):125-33. doi: 10.1016/j.virol.2011.12.002. Epub 2011 Dec 24.

14.

Crystallization and preliminary crystallographic study of human coronavirus NL63 main protease in complex with an inhibitor.

Wang F, Tan Y, Li H, Chen X, Wang J, Li S, Fu S, Zhao Q, Chen C, Su D, Yang H.

Acta Crystallogr F Struct Biol Commun. 2014 Aug;70(Pt 8):1068-71. doi: 10.1107/S2053230X14012953. Epub 2014 Jul 23.

15.

Crystallization and preliminary X-ray crystallographic analysis of the protease inhibitor ecotin in complex with chymotrypsin.

Lee CS, Seong IS, Song HK, Chung CH, Suh SW.

Acta Crystallogr D Biol Crystallogr. 1999 May;55(Pt 5):1091-2.

PMID:
10216315
16.

Structural basis of substrate specificity and protease inhibition in Norwalk virus.

Muhaxhiri Z, Deng L, Shanker S, Sankaran B, Estes MK, Palzkill T, Song Y, Prasad BV.

J Virol. 2013 Apr;87(8):4281-92. doi: 10.1128/JVI.02869-12. Epub 2013 Jan 30.

17.

Crystallization and preliminary diffraction studies of a truncated form of a novel protease from spores of Bacillus megaterium.

Ponnuraj K, Kelly S, Nessi C, Setlow P, Jedrzejas MJ.

Acta Crystallogr D Biol Crystallogr. 2000 Jan;56(Pt 1):70-2.

PMID:
10666631
18.

Crystallization and preliminary X-ray crystallographic analysis of probable amylase/protease inhibitor-B from rice seeds.

Hwang KY, Kim KK, Min K, Eom SH, Yu YG, Kim S, Sweet RM, Suh SW.

J Mol Biol. 1993 Jan 5;229(1):255-7.

PMID:
8421310
19.

Crystallization and preliminary X-ray analysis of peptidyl-tRNA hydrolase from Escherichia coli in complex with the acceptor-TΨC domain of tRNA.

Ito K, Qi H, Shimizu Y, Murakami R, Miura K, Ueda T, Uchiumi T.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Dec 1;67(Pt 12):1566-9. doi: 10.1107/S1744309111038383. Epub 2011 Nov 26.

20.

Structure of equine infectious anemia virus proteinase complexed with an inhibitor.

Gustchina A, Kervinen J, Powell DJ, Zdanov A, Kay J, Wlodawer A.

Protein Sci. 1996 Aug;5(8):1453-65.

Supplemental Content

Support Center